Matairesinol

SKU: orb1684423

Description

Matairesinol is a dietary phytolignan with demonstrated anti-cancer, anti-angiogenic, and anti-fungal properties. Research indicates its anti-osteoporotic potential is linked to inhibiting osteoclastogenesis via p38/ERK-NFATc1 signaling, as shown in cellular studies. This compound is a valuable tool for investigating bone metabolism, oncology, and angiogenesis in experimental models.

Research Area

Immunology & Inflammation, Metabolism Research, Pharmacology & Drug Discovery, Signal Transduction

Images & Validation

−

Key Properties

−

CAS Number	580-72-3
MW	358.39
Purity	99.76%
Formula	C₂₀H₂₂O₆
SMILES	COc1cc(C[C@H]2COC(=O)[C@@H]2Cc2ccc(O)c(OC)c2)ccc1O
Target	ROS,Endogenous Metabolite,p38 MAPK,ATPase

Bioactivity

−

In Vivo

METHODS: A rat sepsis model was established by CLP surgery. On this basis, the rats were given Matairesinol (5, 10, 20 mg/kg, oral administration). Subsequently, blood and IHC were performed to calculate the number of Caspase-3 positive cells and TUNEL staining was performed to detect tissue apoptosis. RESULTS Matairesinol (>5 mg/kg) inhibited the production of S100β, GFAP and NSE; at the same time, the use of Matairesinol on the basis of CLP reduced the damage of CLP to brain tissue and neurons; Matairesinol (>5 mg/kg) significantly inhibited the expression of Caspase-3 and inhibited cell apoptosis.

In Vitro

METHODS: Antiproliferative effect of matairesinol on human pancreatic cancer cells. Cell proliferation was analyzed in PANC-1 and MIA PaCa-2 using different matairesinol treatments (0, 5, 10, 20, 40, 80 and 100 μM). RESULTS The 80 μM concentration of matairesinol inhibited proliferation by 48% in PANC-1 cells and inhibited cellular appreciation by 50% in MIA PaCa-2 cells. METHODS: Immunoblotting images of PCNA were analyzed in PANC-1 and MIA PaCa-2 cells treated with matairesinol (0, 20, 40, and 80 μM), and the inhibitory effect of matairesinol on globule formation was assessed in a three-dimensional (3D) environment using a droplet assay. RESULTS Treatment with matairesinol (80 μM) reduced PCNA expression by 30% and 33% in both PC cell lines; in PANC-1 cells, the relative total area of formed spheroids was reduced by 78% in PANC-1 cells (p < 0.05) and 61% in MIA PaCa-2 cells (p < 0.01). Translated with DeepL.com (free version)

Storage & Handling

−

Storage	Powder: -20°C for 3 years \| In solvent: -80°C for 1 year \| Shipping with blue ice/Shipping at ambient temperature.
Expiration Date	12 months from date of receipt.
Disclaimer	For research use only

Alternative Names

−

ROS, p38MAPK, p38, p38 MAPK, ATPase, Matairesinol

Quality Guarantee

Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at support@biorbyt.com.

Compound Identifiers

PubChem CID

119205 ↗

Key Properties

−

No computed properties available.

Documents Download

Datasheet

Product Information

Download

Request a Document

Protocol Information

Find More Protocols

Matairesinol (orb1684423)

Based on 0 reviews

Participating in our Biorbyt product reviews program enables you to support fellow scientists by sharing your firsthand experience with our products.

No reviews yet

CAS Number:	34446-06-5
MW:	520.53
Formula:	C₂₆H₃₂O₁₁

CAS Number:	198827-23-5
MW:	388.41
Formula:	C₂₁H₂₄O₇

CAS Number:	148409-36-3
MW:	358.39
Formula:	C₂₀H₂₂O₆

CAS Number:	41948-08-7
MW:	682.67
Formula:	C₃₂H₄₂O₁₆

CAS Number:	106647-14-7
MW:	682.25
Formula:	C₃₂H₄₂O₁₆

Matairesinol

Description

Research Area

Images & Validation

Key Properties

Bioactivity

Storage & Handling

Alternative Names

Similar Products

Matairesinol monoglucoside [orb1681301]

(7R)-Methoxy-8-epi-matairesinol [orb1683308]

(+)-Matairesinol [orb1682152]

(8R,8'R)-Matairesinol 4,4'-di-O-β-D-glucopyranoside [orb1941219]

Matairesinol 4′-O-β-D-glucopyranoside [orb1684424]

Quality Guarantee

Compound Identifiers

Key Properties

Documents Download

Request a Document

Protocol Information

Matairesinol (orb1684423)

Step 1: Enter information below

Step 2: Enter the in vivo formulation

Available Sizes

Email

UK Office

US Office

CN Office

Distributors